门静脉系统血栓的发生发展机制

羊媛苑; 王晓艳

doi:10.3969/j.issn.1001-5256.2018.10.005

门静脉系统血栓的发生发展机制

DOI: 10.3969/j.issn.1001-5256.2018.10.005

中南大学湘雅三医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1945
- HTML全文浏览量: 49
- PDF下载量: 435
- 被引次数: 0
出版历程
- 出版日期: 2018-10-20

Mechanisms of the development and progression of portal vein thrombosis

Department of Gastroenterology, The Third Xiangya Hospital of Central South University

摘要

摘要: 门静脉系统血栓(PVT)指门静脉或其分支血管内形成血栓,可导致门静脉高压,引起一系列病理生理变化。PVT通常是由多种病因引起的,主要包括血液高凝状态、门静脉流速降低和血管内皮损伤等。主要探讨了PVT的发病机制,指出临床上应对PVT患者的病因进行全面评估,以协助治疗。
- 静脉血栓形成 /
- 门静脉 /
- 危险因素
Abstract: Portal vein thrombosis ( PVT) refers to the process of thrombosis in the portal vein or its branches and can lead to portal hypertension and a series of pathophysiological changes. PVT is often caused by various etiologies, including hypercoagulable state, reduced portal flow velocity, and vascular endothelial injury. This article reviews the mechanisms of the development and progression of PVT and points out that the etiology of PVT should be evaluated comprehensively to assist treatment.
- venous thrombosis /
- portal vein /
- risk factors

HTML全文

参考文献(48)

[1]OGREN M, BERGQVIST D, BJORCK M, et al.Portal vein thrombosis:prevalence, patient characteristics and lifetime risk:A population study based on 23, 796 consecutive autopsies[J].World JGastroenterol, 2006, 12 (13) :2115-2119.

[2]OKUDA K, OHNISHI K, KIMURA K, et al.Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients[J].Gastroenterology, 1985, 89 (2) :279-286.

[3]JAMIESON NV.Changing perspectives in portal vein thrombosis and liver transplantation[J].Transplantation, 2000, 69 (9) :1772-1774.

[4]YERDEL MA, GUNSON B, MIRZA D, et al.Portal vein thrombosis in adults undergoing liver transplantation:Risk factors, screening, management, and outcome[J].Transplantation, 2000, 69 (9) :1873-1881.

[5]HENDERSON JM, GILMORE GT, MACKAY GJ, et al.Hemodynamics during liver transplantation:The interactions between cardiac output and portal venous and hepatic arterial flows[J].Hepatology, 1992, 16 (3) :715-718.

[6]DE GAETANO AM, LAFORTUNE M, PATRIQUIN H, et al.Cavernous transformation of the portal vein:Patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography[J].AJR Am J Roentgenol, 1995, 165 (5) :1151-1155.

[7]KUMAR A, SHARMA P, ARORA A.Review article:Portal vein obstruction-epidemiology, pathogenesis, natural history, prognosis and treatment[J].Aliment Pharmacol Ther, 2015, 41 (3) :276-292.

[8]D'AMICO M, SAMMARCO P, PASTA L.Thrombophilic genetic factors PAI-1, MTHFRC677T, V Leiden 506Q, and prothrombin20210A in noncirrhotic portal vein thrombosis and budd-chiari syndrome in a caucasian population[J].Int J Vasc Med, 2013, 2013:717480.

[9]de BRUIJNE EL, DARWISH MURAD S, de MAAT MP, et al.Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis[J].Thromb Haemost, 2007, 97 (2) :181-185.

[10]MARTINELLI I, PRIMIGNANI M, AGHEMO A, et al.High levels of factor VIII and risk of extra-hepatic portal vein obstruction[J].J Hepatol, 2009, 50 (5) :916-922.

[11]QI X, REN W, DE STEFANO V, et al.Associations of coagulation factor V Leiden and prothrombin G20210A mutations with BuddChiari syndrome and portal vein thrombosis:A systematic review and meta-analysis[J].Clin Gastroenterol Hepatol, 2014, 12 (11) :1801-1812, e1807.

[12]NERY F, CHEVRET S, CONDAT B, et al.Causes and consequences of portal vein thrombosis in 1, 243 patients with cirrhosis:results of a longitudinal study[J].Hepatology, 2015, 61 (2) :660-667.

[13]QI X, WU F, HE C, et al.Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis:an observational study with a systematic review of the literature[J].Eur J Gastroenterol Hepatol, 2015, 27 (1) :77-83.

[14]QI X, DE STEFANO V, WANG J, et al.Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome:A systematic review and meta-analysis of observational studies[J].J Gastroenterol Hepatol, 2013, 28 (3) :432-442.

[15]AMITRANO L, BRANCACCIO V, GUARDASCIONE MA, et al.Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients:Role of genetic thrombophilia[J].Endoscopy, 2002, 34 (7) :535-538.

[16]WALKER AP.Portal vein thrombosis:What is the role of genetics?[J].Eur J Gastroenterol Hepatol, 2005, 17 (7) :705-707.

[17]ERKAN O, BOZDAYI AM, DISIBEYAZ S, et al.Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis[J].Eur J Gastroenterol Hepatol, 2005, 17 (3) :339-343.

[18]VIOLI F, FERRO D, SALIOLA M, et al.Evaluation of D-dimer in patients with liver cirrhosis[J].Thromb Haemost, 1989, 62 (4) :1149-1150.

[19]CHAWLA Y, DUSEJA A, DHIMAN RK.Review article:the modern management of portal vein thrombosis[J].Aliment Pharmacol Ther, 2009, 30 (9) :881-894.

[20]TEFFERI A, THIELE J, ORAZI A, et al.Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis:Recommendations from an ad hoc international expert panel[J].Blood, 2007, 110 (4) :1092-1097.

[21]QI X, ZHANG C, HAN G, et al.Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis:a prospective study[J].J Gastroenterol Hepatol, 2012, 27 (6) :1036-1043.

[22]DEEPAK A, PUNAMIYA S, PATEL N, et al.Prevalence of JAK29V617F mutation in intra-abdominal venous thrombosis[J].Trop Gastroenterol, 2011, 32 (4) :279-284.

[23]KLAMPFL T, GISSLINGER H, HARUTYUNYAN AS, et al.Somatic mutations of calreticulin in myeloproliferative neoplasms[J].N Engl JMed, 2013, 369 (25) :2379-2390.

[24]NANGALIA J, MASSIE CE, BAXTER EJ, et al.Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2[J].N Engl J Med, 2013, 369 (25) :2391-2405.

[25]LI M, de STEFANO V, SONG T, et al.Prevalence of CALR mutations in splanchnic vein thrombosis:A systematic review and meta-analysis[J].Thromb Res, 2018, 167:96-103.

[26]ZIAKAS PD, POULOU LS, ROKAS GI, et al.Thrombosis in paroxysmal nocturnal hemoglobinuria:Sites, risks, outcome.An overview[J].J Thromb Haemost, 2007, 5 (3) :642-645.

[27]QI X, HE C, HAN G, et al.Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis[J].J Gastroenterol Hepatol, 2013, 28 (1) :148-152.

[28]AGENO W, DENTALI F, de STEFANO V, et al.Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis[J].Thromb Res, 2014, 133 (6) :1052-1055.

[29]QI X, de STEFANO V, SU C, et al.Associations of antiphospholipid antibodies with splanchnic vein thrombosis:A systematic review with meta-analysis[J].Medicine (Baltimore) , 2015, 94 (4) :e496.

[30]QI X, YANG Z, de STEFANO V, et al.Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis:A systematic review and meta-analysis of observational studies[J].Hepatol Res, 2014, 44 (14) :e480-e498.

[31]NI YH, WANG NC, PENG MY, et al.Bacteroides fragilis bacteremia associated with portal vein and superior mesentery vein thrombosis secondary to antithrombin III and protein C deficiency:a case report[J].JMicrobiol Immunol Infect, 2002, 35 (4) :255-258.

[32]BUREAU C, LAURENT J, ROBIC MA, et al.Central obesity is associated with non-cirrhotic portal vein thrombosis[J].J Hepatol, 2016, 64 (2) :427-432.

[33]ZAKKO A, T KRONER P, NANKANI R, et al.Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients[J].Gastroenterol Hepatol Bed Bench, 2018, 11 (2) :153-158.

[34]BASTARD JP, PIERONI L.Plasma plasminogen activator inhibitor1, insulin resistance and android obesity[J].Biomed Pharmacother, 1999, 53 (10) :455-461.

[35]SCHAFER K, KONSTANTINIDES S.Mechanisms linking leptin to arterial and venous thrombosis:Potential pharmacological targets[J].Curr Pharm Des, 2014, 20 (4) :635-640.

[36]ZIRONI G, GAIANI S, FENYVES D, et al.Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension[J].J Hepatol, 1992, 16 (3) :298-303.

[37]ZOCCO MA, DI STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.

[38]ZOLI M, IERVESE T, MERKEL C, et al.Prognostic significance of portal hemodynamics in patients with compensated cirrhosis[J].J Hepatol, 1993, 17 (1) :56-61.

[39]QI XS, BAI M, FAN DM.Nonselective beta-blockers may induce development of portal vein thrombosis in cirrhosis[J].World J Gastroenterol, 2014, 20 (32) :11463-11466.

[40]ZAMPINO R, LEBANO R, COPPOLA N, et al.The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients[J].Saudi J Gastroenterol, 2018, 24 (1) :25-29.

[41]PLESSIER A, DARWISH-MURAD S, HERNANDEZ-GUERRA M, et al.Acute portal vein thrombosis unrelated to cirrhosis:A prospective multicenter follow-up study[J].Hepatology, 2010, 51 (1) :210-218.

[42]DORFFEL T, WRUCK T, RUCKERT RI, et al.Vascular complications in acute pancreatitis assessed by color duplex ultrasonography[J].Pancreas, 2000, 21 (2) :126-133.

[43]ZHENG RQ, KUDO M, INUI K, et al.Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma[J].J Gastroenterol, 2003, 38 (1) :101-103.

[44]HABU D, NISHIGUCHI S, SHIOMI S, et al.Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma[J].Indian J Gastroenterol, 2002, 21 (4) :162-163.

[45]MATSUMOTO K, YAMAO K, OHASHI K, et al.Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer:Case report[J].Gastrointest Endosc, 2003, 57 (2) :269-271.

[46]VALI T, TEIN A, TIGANIK V, et al.Vascular complications after orthotopic liver transplantation in Estonia[J].Transplant Proc, 2013, 45 (3) :1201-1203.

[47]MOHAN N, KARKRA S, RASTOGI A, et al.Outcome of 200 pediatric living donor liver transplantations in India[J].Indian Pediatr, 2017, 54 (11) :913-918.

[48]JAIN M, JAIN J, PASSI GR, et al.Profile of extrahepatic portal venous obstruction among children in Central India[J].Clin Exp Hepatol, 2017, 3 (4) :209-211.

施引文献

资源附件(0)

访问统计